Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Ropivacaina Molteni 150mg/20ml*

Ropivacaina Molteni 150mg/20ml* :
Type Medicine Non Marketed
Originator Naropin 150mg*
Agent Macromed
Distributor Macromed
Laboratory Molteni Farmaceutici
Responsible Party L. Molteni & C.dei F.LLi Alitti societa.di.Eserci
Origin Italy
Manufacturer L. Molteni & C.
Manufacturing Type G
Origin Italy
ATC N01BB09

Your comment will appear shortly after approval

Ropivacaina Molteni 150mg/20ml* :

Revision Date : 01/10/2015


Effect Frequency
Allergic reaction Rare
Anaphylactic reactions Rare
Angioedema (Angioneurotic oedema) (Quincke oedema) Rare
Anxiety Uncommon
Arrhythmia Rare
Back pain Common
Body temperature increased Common
Bradycardia Common
Cardiac arrest Rare
Cephalea Common
Chills Common
Convulsion Uncommon
Dizziness Common
Dysarthria Uncommon
Dyskinesia Not known
Dyspnoea (dyspnea) Uncommon
Grand mal convulsion Uncommon
Hyperacusis Uncommon
Hypertension Common
Hypoesthesia Uncommon
Hypotension Very Common
Hypothermia Uncommon
Lightheadedness Uncommon
Muscle twitching (Muscle twitch) Uncommon
Nausea Very Common
Numbness of tongue Uncommon
Paraesthesia (paresthesia) Common
Perioral paraesthesia Uncommon
Syncope Uncommon
Tachycardia Common
Tinnitus Uncommon
Tremor Uncommon
Urinary retention Common
Urticaria Rare
Visual disturbance Uncommon
Vomiting Common

Different Units By MoH Code

Revision Date : 01/09/2011

Ropivacaina Molteni 150mg/20ml*  MoH 7102 :
Form Solution for infusion
Packaging Ampoules
Package Size 5x20ml
Strength 150mg
NSSF ✘
Quarantine ✘
Reg. Number 186266/13
Submission date 01/01/2013
Registration Year 2013
Archived Date 2018


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info